US 8361958
Oximyl HCV serine protease inhibitors
granted A61KA61K38/21
Quick answer
US patent 8361958 (Oximyl HCV serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K38/21